drugset / Trial / NCT00322062

MOVIPREP® Versus NaP Pivotal Phase III Study

NCT00322062 ↗

Phase 3 Completed 340 enrolled Norgine
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of the study is to compare a new 2 litre bowel cleansing product versus a sodium phosphate solution already on the market. Efficacy of each bowel preparation, safety and acceptability will be assessed.

Timeline

Start
2002-04
Primary completion
—
Completion
2003-03

Drugs

EvaluationDrugModalityDoseRoute
Subject NRL994 Unknown 2000 ml Oral
Comparator Sodium Phosphate Solution Unknown 45 ml Oral

Indications

No indication recorded.